SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,097 | -38.2% | 461,209 | +24.3% | 0.00% | 0.0% |
| Q2 2023 | $1,776 | +184.6% | 370,905 | +237.0% | 0.00% | – |
| Q1 2023 | $624 | -36.9% | 110,060 | -37.7% | 0.00% | – |
| Q4 2022 | $989 | -99.9% | 176,669 | +12.1% | 0.00% | -100.0% |
| Q3 2022 | $1,012,000 | +666.7% | 157,575 | +309.4% | 0.00% | – |
| Q2 2022 | $132,000 | 0.0% | 38,488 | +106.5% | 0.00% | – |
| Q1 2022 | $132,000 | -97.0% | 18,637 | -96.4% | 0.00% | -100.0% |
| Q4 2021 | $4,360,000 | +1205.4% | 523,398 | +991.9% | 0.00% | – |
| Q3 2021 | $334,000 | -42.6% | 47,934 | +96.8% | 0.00% | – |
| Q2 2021 | $582,000 | -48.6% | 24,362 | -55.7% | 0.00% | -100.0% |
| Q1 2021 | $1,133,000 | +96.0% | 55,015 | +132.7% | 0.00% | – |
| Q4 2020 | $578,000 | -32.9% | 23,639 | -22.3% | 0.00% | -100.0% |
| Q3 2020 | $862,000 | +538.5% | 30,427 | +7.9% | 0.00% | – |
| Q2 2020 | $135,000 | +214.0% | 28,204 | +132.8% | 0.00% | – |
| Q1 2020 | $43,000 | -65.9% | 12,116 | -66.8% | 0.00% | – |
| Q4 2019 | $126,000 | +59.5% | 36,539 | +85.1% | 0.00% | – |
| Q3 2019 | $79,000 | +68.1% | 19,737 | +36.5% | 0.00% | – |
| Q2 2019 | $47,000 | +9.3% | 14,459 | +130.4% | 0.00% | – |
| Q1 2019 | $43,000 | +4200.0% | 6,276 | +2689.3% | 0.00% | – |
| Q4 2018 | $1,000 | -98.3% | 225 | -97.1% | 0.00% | – |
| Q3 2018 | $60,000 | +200.0% | 7,859 | +241.0% | 0.00% | – |
| Q2 2018 | $20,000 | -64.3% | 2,305 | -69.6% | 0.00% | – |
| Q1 2018 | $56,000 | -82.3% | 7,589 | -75.7% | 0.00% | – |
| Q4 2017 | $317,000 | -73.6% | 31,245 | -58.3% | 0.00% | -100.0% |
| Q3 2017 | $1,202,000 | +594.8% | 74,949 | +391.6% | 0.00% | – |
| Q2 2017 | $173,000 | -56.0% | 15,246 | -56.4% | 0.00% | – |
| Q1 2017 | $393,000 | +882.5% | 34,944 | +763.0% | 0.00% | – |
| Q4 2016 | $40,000 | -57.4% | 4,049 | -47.5% | 0.00% | – |
| Q3 2016 | $94,000 | +422.2% | 7,707 | +1180.2% | 0.00% | – |
| Q2 2016 | $18,000 | +260.0% | 602 | +198.0% | 0.00% | – |
| Q1 2016 | $5,000 | -80.0% | 202 | -71.7% | 0.00% | – |
| Q4 2015 | $25,000 | – | 714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |